Skip to main content
logo
TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.7550
+0.0048 (0.64%)
Aug 28, 2026, 10:09 AM EDT - Market open

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Development of TCR-T Therapies for Treatment of Patients with Cancer
10.33M2.82M21.05M13.54M10.14M
Total
10.33M2.82M21.05M13.54M10.14M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
10.33M2.82M21.05M13.54M10.14M
Total
10.33M2.82M21.05M13.54M10.14M